KR101229055B1 - Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same - Google Patents
Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same Download PDFInfo
- Publication number
- KR101229055B1 KR101229055B1 KR1020100053583A KR20100053583A KR101229055B1 KR 101229055 B1 KR101229055 B1 KR 101229055B1 KR 1020100053583 A KR1020100053583 A KR 1020100053583A KR 20100053583 A KR20100053583 A KR 20100053583A KR 101229055 B1 KR101229055 B1 KR 101229055B1
- Authority
- KR
- South Korea
- Prior art keywords
- alginic acid
- strain
- hjm27
- alginate
- resolution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000589309 Methylobacterium sp. Species 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title claims description 24
- 238000000354 decomposition reaction Methods 0.000 title claims description 3
- 230000000694 effects Effects 0.000 title description 40
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 162
- 229920000615 alginic acid Polymers 0.000 claims abstract description 162
- 229960001126 alginic acid Drugs 0.000 claims abstract description 125
- 239000000783 alginic acid Substances 0.000 claims abstract description 125
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 124
- 102000004190 Enzymes Human genes 0.000 claims abstract description 65
- 108090000790 Enzymes Proteins 0.000 claims abstract description 65
- 239000011942 biocatalyst Substances 0.000 claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 241001474374 Blennius Species 0.000 claims abstract description 14
- 241000589323 Methylobacterium Species 0.000 claims abstract description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 62
- 239000002609 medium Substances 0.000 claims description 42
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 37
- 239000001888 Peptone Substances 0.000 claims description 37
- 108010080698 Peptones Proteins 0.000 claims description 37
- 229940072056 alginate Drugs 0.000 claims description 37
- 235000019319 peptone Nutrition 0.000 claims description 37
- 239000011780 sodium chloride Substances 0.000 claims description 31
- 229940041514 candida albicans extract Drugs 0.000 claims description 30
- 239000012138 yeast extract Substances 0.000 claims description 30
- 230000012010 growth Effects 0.000 claims description 22
- 239000001963 growth medium Substances 0.000 claims description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- 238000012258 culturing Methods 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 2
- 230000015784 hyperosmotic salinity response Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 39
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 28
- 230000000593 degrading effect Effects 0.000 description 28
- 235000000346 sugar Nutrition 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 241000894006 Bacteria Species 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 16
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 14
- 229910052757 nitrogen Inorganic materials 0.000 description 14
- 239000000661 sodium alginate Substances 0.000 description 14
- 235000010413 sodium alginate Nutrition 0.000 description 14
- 229940005550 sodium alginate Drugs 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000011534 incubation Methods 0.000 description 12
- 241000195493 Cryptophyta Species 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 description 7
- 241000199919 Phaeophyceae Species 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 108090000856 Lyases Proteins 0.000 description 6
- 102000004317 Lyases Human genes 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 235000010419 agar Nutrition 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 239000013028 medium composition Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 5
- 241001658959 Methylobacterium sp. HJM27 Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 230000002062 proliferating effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241001135756 Alphaproteobacteria Species 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 229920000985 (beta-D-Mannuronate)n Polymers 0.000 description 2
- 241000251511 Holothuroidea Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000237921 Urechis unicinctus Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003627 anti-cholesterol Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 108010004131 poly(beta-D-mannuronate) lyase Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007686 pys medium Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000965254 Apostichopus japonicus Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000920701 Batillus Species 0.000 description 1
- 241001463014 Chazara briseis Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000237890 Haliotis Species 0.000 description 1
- 241000143510 Haliotis discus hannai Species 0.000 description 1
- 241000251592 Halocynthia Species 0.000 description 1
- 241000251591 Halocynthia roretzi Species 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000258161 Stichopus Species 0.000 description 1
- 241000950638 Symphysodon discus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000251555 Tunicata Species 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- -1 alginic acid oligosaccharides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 230000001164 bioregulatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 238000011392 neighbor-joining method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 알긴산 분해능을 갖는 메틸로박테리움 속(Methylobacterium sp.) 균주, 상기 선별된 메틸로박테리움 속 균주로부터 제조한 알긴산 분해능을 갖는 생촉매 및 상기 생촉매를 이용하여 알긴산 올리고머을 제조하는 방법에 관한 것으로, 특히 상기 메틸로박테리움 속 균주는 기존 보고된 알긴산 분해능을 갖는 미생물에 비하여 현저하게 우수한 알긴산 분해능이 인정되므로, 알긴산으로부터 제조된 알긴산 올리고머가 이용되는 식품, 화장품 및 의약품과 관련된 산업분야 또는 해조류를 이용한 바이오에너지 생산 등과 관련된 다양한 산업에 유용하게 사용될 수 있다.The present invention is a Methylobacterium sp. Strain having alginic acid resolution, a biocatalyst having alginic acid resolution prepared from the selected strains of Methylobacterium sp., And a method for producing an alginic acid oligomer using the biocatalyst. In particular, since the strain of the genus Methylobacterium is recognized to have a significantly superior alginic acid resolution compared to a microorganism having a previously reported alginic acid resolution, the industrial field related to food, cosmetics and medicines using alginic acid oligomer prepared from alginic acid or It can be usefully used in various industries related to bioenergy production using seaweed.
Description
본 발명은 알긴산 분해능을 갖는 메틸로박테리움 속(Methylobacterium sp.) 균주 및 상기 메틸로박테리움 속 균주를 이용하여 알긴산 올리고머를 제조하는 방법에 관한 것이다.The present invention relates to a methyloacterium sp. Strain having alginic acid resolution and a method for preparing an alginic acid oligomer using the strains of the methyllobacterium sp.
알긴산(alginic acid)은 주로 갈조류의 세포벽을 구성하고 있어, 갈조류로부터 추출할 수 있다. 알긴산은 α-L-글루론산(guluronate)과 C5 에피머(epimer)인 β-D-만뉴론산(1,4’-β-D-mannuronate)이 α-1,4 결합 또는 β-1,4 결합으로 이루어진 hetero형 다당류로, pG block, pM block 및 pM/G stretch 형식으로 결합된 복잡한 당중합체이다.Alginic acid mainly forms the cell wall of brown algae and can be extracted from brown algae. Alginic acid is α-1,4 bond or β-1,4 by α-L-guluronate and β-D-manneuronic acid (1,4'-β-D-mannuronate), a C5 epimer. Heteropolysaccharide is a complex polysaccharide composed of pG block, pM block and pM / G stretch.
상기 알긴산은 독특한 물리적 성질 때문에 예로부터 광범위하게 사용되어 왔다. 예를 들어, 식품산업, 인쇄산업 및 제약산업을 포함한 다양한 산업분야에서 안정제, 점질제 또는 겔화제로 사용되고, 미립구, 비드, 마이크로캡슐 또는 정제 등과 같은 약물전달시스템의 원료로 사용되며, 조직공학에서 매트릭스 담체 등으로 사용되어 왔다. 또한, 알긴산은 비만 억제, 장의 연동운동 촉진을 통한 변비 치유, 항콜레스테롤 억제, 체내의 중금속 흡수와 제거 또는 유해물질의 독성 억제와 같은 다양한 생리활성이 보고되어, 기존 용도에 추가로 기능성 식품소재로 활용하기 위한 연구가 진행되고 있다.The alginic acid has been widely used since ancient times because of its unique physical properties. For example, it is used as a stabilizer, viscous or gelling agent in various industries including food industry, printing industry and pharmaceutical industry, as raw material of drug delivery system such as microspheres, beads, microcapsules or tablets, matrix in tissue engineering It has been used as a carrier and the like. In addition, alginic acid has been reported to have various physiological activities such as restraining obesity, healing constipation through promoting intestinal peristalsis, inhibiting anti-cholesterol, absorbing and removing heavy metals in the body, or inhibiting the toxicity of harmful substances. Research is underway to utilize it.
또한, 상처를 보호하는 창상피복재 및 지혈 등의 생리활성효과를 가지고 있는 것으로 알려져 있을 뿐만 아니라, 최근 알긴산 유래 올리고당의 항균/항암 작용, 면역 증강, 항콜레스테롤 효과, 항응고 효과 등 다양한 생체조절 기능에 대해 보고되었다. 이러한 다양한 기능성으로 인해 알긴산 자체뿐만 아니라 알긴산을 이용한 올리고당 제조에 관한 연구가 다양하게 진행되고 있다.In addition, it is known to have a physiological activity effect such as wound dressings and hemostasis to protect the wound, as well as a variety of bioregulatory functions such as antimicrobial / anticancer activity, immune enhancement, anticholesterol effect, anticoagulant effect of alginic acid-derived oligosaccharides. Has been reported. Due to such various functionalities, research on preparing oligosaccharides using alginic acid as well as alginic acid itself is being conducted in various ways.
기존 알긴산을 제조하는 방법은 갈조류와 같은 해조류에서 알긴산 또는 알긴산 유래 올리고당 등과 같은 유효성분을 추출하는 방법들이 제시되어 있다. 일 예로, 고압처리, 고온고압처리 또는 방사선처리를 통해 해조류를 연화시킨 뒤 추출하는 방법 또는 산 알칼리 처리를 이용한 방법 등이 보고되고 있다. 그러나, 기존의 방법은 해조류 유래의 탄수화물 대부분이 산이나 알칼리에 비교적 안정하기 때문에 알긴산의 추출에 다소 어려움이 있어 추출효율이 낮다는 문제점이 있다.Existing alginic acid is a method of extracting an active ingredient such as alginic acid or alginic acid-derived oligosaccharides from seaweeds such as brown algae. For example, a method of softening and extracting algae through high pressure treatment, high temperature and high pressure treatment or radiation treatment, or a method using acid alkali treatment has been reported. However, the conventional method has a problem that the extraction efficiency of the alginic acid is somewhat difficult because most carbohydrates derived from seaweed are relatively stable to acid or alkali.
따라서, 최근에는 기능성 해조 올리고당을 생산하기 위해, 해조 유래 다당류를 화학적으로 분해하는 화학적 분해방법 보다는 효소를 이용한 효소적 분해방법에 대한 관심이 증대되고 있다.Therefore, in recent years, in order to produce functional seaweed oligosaccharides, interest in enzymatic degradation using enzymes rather than chemical degradation of chemically degrading seaweed-derived polysaccharides has been increasing.
알긴산을 분해하는 분해효소인 알지네이트 분해효소(alginate lyase)는 그 분해 기전이 명확하게 밝혀져 있지는 아니하나, β-elimination 반응에 의한 알긴산 분해반응을 수행하는 것으로 알려져 있다. 알지네이트 분해효소는 pM-block(polymannuronate block) 또는 pG-block(polyguluronate block)에 작용하여 주로 어떤 위치를 분해하느냐에 따라 분류되며, 한 종류는 만뉴로네이트(mannuronate)와 만뉴로네이트(mannuronate) 사이의 β-1,4 당결합을 분해하는 알지네이트 분해효소(EC 4.2.2.3, β-D-mannuronan lyase)이고, 다른 한 종류는 글루로네이트(guluronate)와 글루로네이트(guluronate) 사이의 α-1,4 당결합을 분해하는 알지네이트 분해효소(EC 4.2.2.11, α-D-guluronan lyase)이다.Alginate lyase, a degrading enzyme that decomposes alginic acid, is not known for its decomposition mechanism, but is known to perform alginic acid degradation by β-elimination. Alginate degrading enzymes are classified according to their location on the pM-block (polymannuronate block) or pG-block (polyguluronate block) to break down, and one type is between mannuronate and mannuronate. Alginate degrading enzymes (EC 4.2.2.3, β-D-mannuronan lyase) that degrade β-1,4 sugar bonds, and the other type α-1 between gluuronate and guluronate And alginate degrading enzymes (EC 4.2.2.11, α-D-guluronan lyase) that break down sugar bonds.
다양한 용도로 산업적 이용이 가능한 알긴산 올리고당의 효율적 생산을 위해서는 알긴산 분해효소가 필요하므로, 이를 위해서 알긴산 분해효소를 분비하는 미생물의 탐색을 위한 연구가 필요하다.In order to efficiently produce alginic acid oligosaccharides that can be industrially used for various purposes, alginic acid degrading enzymes are required. Therefore, research for the search for microorganisms that secrete alginic acid degrading enzymes is necessary.
최근 화석연료에 의한 환경오염과 원유 등 자원고갈과 같은 사회 문제로 인해 재생 가능한 에너지에 대한 관심이 고조되고 있으며, 자연계의 생물량을 이용한 바이오에너지 생산 관련 연구들이 주목받고 있다. 특히 옥수수 등 식량자원을 이용한 바이오에너지 생산의 문제점을 극복하기 위한 대안으로 해조류를 이용한 바이오에너지의 생산과 관련된 연구가 주목을 받고 있으며, 해조류를 이용한 바이오에너지 생산을 위해서는 해조류의 세포벽을 구성하는 알긴산을 분해할 수 있는 분해능이 우수한 분해효소에 대한 개발이 요구된다.Recently, due to social problems such as environmental pollution caused by fossil fuels and depletion of resources such as crude oil, interest in renewable energy is increasing, and researches related to bioenergy production using biomass of nature are attracting attention. In particular, research on the production of bioenergy using seaweed has attracted attention as an alternative to overcome the problems of bioenergy production using food resources such as corn.Alginate, which forms the cell wall of algae, is used for bioenergy production using seaweed. There is a need for development of a degrading enzyme that can decompose is excellent.
상기와 같은 필요성에 따라, 본 발명은 알긴산 분해능이 우수한 신규한 미생물을 제공하는 것을 목적으로 한다.According to the necessity as described above, an object of the present invention is to provide a novel microorganism having excellent alginic acid resolution.
또한, 본 발명은 상기와 같은 필요성에 따라, 알긴산 분해능을 갖는 생촉매(biocatalyst)를 이용한 알긴산 올리고머의 제조방법을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a method for preparing an alginic acid oligomer using a biocatalyst having alginic acid resolution according to the necessity as described above.
상기 목적을 달성하기 위하여, 본 발명은 알긴산 분해능을 갖는 메틸로박테리움 속 균주(Methylobacterium sp.)를 제공한다.In order to achieve the above object, the present invention provides a methylobacterium sp. ( Methylobacterium sp.) Having an alginic acid resolution.
또한, 본 발명은 상기 메틸로박테리움 속 균주(Methylobacterium sp.), 상기 균주의 배양액 및 상기 배양액의 농축액으로 이루어지는 군에서 선택된 1종 이상을 포함하는 알긴산 분해능을 갖는 생촉매(biocatalyst)를 제공한다.In another aspect, the present invention provides a biocatalyst having an alginic acid resolution including at least one selected from the group consisting of the Methylobacterium sp., A culture of the strain and a concentrate of the culture. .
또한, 본 발명은 상기 알긴산 분해능을 갖는 생촉매를 해조류와 반응시키는 단계를 포함하는 알긴산 올리고머의 제조방법을 제공한다.In addition, the present invention provides a method for producing an alginic acid oligomer comprising the step of reacting the biocatalyst having the alginic acid resolution with seaweeds.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명자들은 해조류를 식이하는 해양 동물의 내장으로부터 분리한 신규한 메틸로박테리움속 균주(Methylobacterium sp.)인 메틸로박테리움 속 HJM27(Methylobacterium sp. HJM27)이 우수한 알긴산 분해능을 갖는다는 것을 확인하여 본 발명을 완성하였다.To check that the present inventors have superior alginate resolution tumefaciens in HJM27 (Methylobacterium sp. HJM27) to the methyl novel methyl isolated from internal tumefaciens sp (Methylobacterium sp.) Of marine animals that dietary algae The present invention has been completed.
본 발명에 있어서, 알긴산(alginic acid)은 주로 갈조류와 같은 해조류의 세포벽을 구성하는 다당류로, α-L-글루론산(guluronate)과 C5 에피머(epimer)인 β-D-만뉴론산(1,4’-β-D-mannuronate)이 α-1,4 결합 또는 β-1,4 결합으로 이루어진 hetero형 다당류이다. 상기 알긴산은 알지네이트 또는 해초산이라고도 하며, 상기 알긴산은 폴리글루론산 블록(polyguluronate block, pG block), 폴리만뉴론산 블록(polymannuronate block, pM block) 및 폴리글루론산-폴리만뉴론산 블록(polyguluronate-mannuronate block, pM/G block 또는 pG/M block)으로 결합된 복잡한 당중합체이다.In the present invention, alginic acid (alginic acid) is a polysaccharide constituting the cell wall of algae, mainly brown algae, α-L- gluronate (guluronate) and C5 epimer (β-D-manneuronic acid (1, 4'-β-D-mannuronate) is a heteropolysaccharide consisting of α-1,4 bond or β-1,4 bond. The alginic acid is also referred to as alginate or sea acetate, and the alginic acid is polyguluronate block (pG block), polymannuronate block (pM block) and polygluronic acid-polymanuronic acid block (polyguluronate- mannuronate block, pM / G block or pG / M block).
본 발명에 있어서, 알긴산을 분해하는 분해효소인 알지네이트 분해효소는 알지네이즈(alginase) 또는 알지네이트 디폴리머레이즈(alginate depolymerase)라고 하며, 그 분해에 대한 완전한 기전은 아직까지 밝혀지지 않았으나 β-elimination 반응을 통해 알긴산을 분해할 수 있는 분해능을 가진 효소이다. 상기 알긴산은 알긴산의 β-1,4-glycosidic 결합을 분해하여 4,5-unsaturated nonreducing 말단을 갖는 산물을 만들 수 있다. 상기 알긴산 분해효소는 만뉴론산(mannuronate)과 만뉴론산(mannuronate) 사이의 β-1,4 당결합을 분해하는 알지네이트 분해효소(poly(M) lyase, (1→4)-β-D-mannuronan lyase, EC 4.2.2.3)와 글루론산(guluronate)과 글루론산(guluronate) 사이의 α-1,4 당결합을 분해하는 알지네이트 분해효소(poly(G) lyase, (1→4)-α-L-guluronan lyase, EC 4.2.2.11)가 있다.In the present invention, alginate degrading enzyme, which is a degrading enzyme that decomposes alginic acid, is called alginase or alginate depolymerase. It is an enzyme that can decompose alginic acid through. The alginic acid can break down β-1,4-glycosidic bonds of alginic acid to produce products having 4,5-unsaturated nonreducing ends. The alginic acid degrading enzyme is a poly (M) lyase (1 → 4) -β-D-mannuronan lyase that breaks down β-1,4 sugar bonds between mannuronate and mannuronate. , EC 4.2.2.3) and poly (G) lyases (1 → 4) -α-L- that break down α-1,4 sugar bonds between guluronate and guluronate guluronan lyase, EC 4.2.2.11).
본 발명에 있어서, 생촉매(biocatalyst)란 여러 가지 화학반응 또는 생화학반응에서 촉매의 역할을 하는 미생물 또는 미생물이 분비하는 물질을 포함하는 것일 수 있고, 일 예로 화학반응 또는 생화학반응을 촉매하는 미생물, 미생물 배양액 및 이들의 혼합물을 포함하는 것일 수 있다.In the present invention, the biocatalyst may include a microorganism that acts as a catalyst in various chemical reactions or biochemical reactions or a substance secreted by the microorganisms, for example, a microorganism that catalyzes a chemical reaction or a biochemical reaction, It may include a microbial culture and a mixture thereof.
본 발명에 있어서, 배지(culture medium)란 미생물이나 동식물의 조직을 배양하기 위하여 배양체가 필요로 하는 영양물질을 주성분으로 포함하거나, 특수한 목적을 위하여 상기 주성분 외에 추가적인 물질을 더욱 포함하는 것을 의미하며, 배양배지, 배양기 또는 배양액이라고도 한다. 상기 배지는 천연배지, 합성배지 또는 선택배지가 있고, 성상에 따라 고체배지 또는 액체배지가 있으나, 이에 한정되는 것은 아니다.In the present invention, the culture medium means that the nutrients required by the culture medium for cultivating the tissues of microorganisms or animals or animals are included as main ingredients, or further include additional substances in addition to the main ingredients for special purposes. Also called culture medium, incubator or culture solution. The medium may be a natural medium, a synthetic medium or a selective medium, there are solid or liquid medium depending on the properties, but is not limited thereto.
본 발명은 알긴산 분해능을 갖는 메틸로박테리움 속 균주에 관한 것이다. 상기 메틸로박테리움 속 균주는 메틸로박테리움 속 HJM27(Methylobacterium sp. HJM27)일 수 있다.The present invention relates to a strain of Methylbacterium genus having alginic acid resolution. Tumefaciens sp to the methyl may be methyl tumefaciens in HJM27 (Methylobacterium sp. HJM27).
본 발명의 일 예에서, 본 발명에 따른 알긴산 분해능을 갖는 균주 탐색은 2단계로 진행되었다. 상세하게는, 상기 균주 탐색은 1차로 해조류를 식이하는 해양 동물, 구체적으로 전복(Haliotis discus hannai), 소라(Batillus cornutus), 해삼(Stichopus japonicus), 멍게(Halocynthia roretzi) 및 개불(Urechis unicinctus)의 내장에서 얻은 시료로부터 알긴산 분해능이 있는 균주를 분리하고, 2차로 1차로 선별된 균주의 알긴산 분해능을 검토하여 가장 분해능이 우수한 균주를 선별하는 방법으로 수행하였다.In one embodiment of the present invention, the strain with alginic acid resolution according to the present invention proceeded in two steps. Specifically, the strain search is primarily for marine animals dieting algae, specifically Haliotis discus hannai , seashell ( Billillus) cornutus ), sea cucumber ( Stichopus) japonicus ), sea squirt ( Halocynthia roretzi ), and doghouse ( Urechis unicinctus ) was isolated from the sample obtained in the gut of the alginate, and the alginate resolution of the first screened strain was examined by selecting the strain having the highest resolution.
상기의 탐색과정을 통하여, 알긴산 분해능이 우수한 것으로 선별된 균주는 동정 결과 메틸로박테리움 속인 것으로 확인되었다. 상세하게는, 상기 선별된 균주의 16S rDNA 염기서열 분석결과, 본 발명의 선별된 균주인 HJM27은 도 2에 나타낸 바와 같이, 알파프로테오 박테리아(alphaproteobacteria)인 메틸로박테리움 속(Methylobacterium sp.) 세균과 가장 높은 유사성(99%)을 나타내는 것으로 확인되어, 메틸로박테리움 속 HJM27(Methylobacterium sp. HJM27)로 명명하였다.Through the above search, the strains selected as having excellent alginate resolution were identified as belonging to the genus Methylobacterium. Specifically, as a result of 16S rDNA sequencing analysis of the selected strain, the selected strain HJM27 of the present invention, as shown in Figure 2, alphaproteobacteria ( alphaproteobacteria ) Methylobacterium sp. It is showed a bacteria with the highest similarity (99%), which was designated as tumefaciens in HJM27 (Methylobacterium sp. HJM27) methyl.
상기 메틸로박테리움 속 HJM27을 대한민국 대전광역시 유성구에 위치한 생물자원센터에 2010년 4월 13일자로 기탁하여 기탁번호 KCTC 11680BP를 부여받았다.The HJM27 in the methylobacterium was deposited on April 13, 2010 at the Biological Resource Center located in Yuseong-gu, Daejeon, Korea, and received the accession number KCTC 11680BP.
상기 메틸로박테리움 속 HJM27(KCTC 11680BP)은 알긴산 분해 활성이 우수한 것으로 확인된 알긴산 분해효소 생성균주이고, 배지 내 NaCl 농도가 2.5%일 때에 비해 3.0%일 때 성장속도가 급격히 저하되었으므로, 내염성 균주(halotolerant stain)로 확인되었다. 상기 확인된 결과에 의하면, 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)은 배지 내 NaCl 함량은 전체 조성물의 부피 대비 NaCl의 중량에 관한 농도로 표현(NaCl의 함량(w)/전체 배지 부피(v))될 수 있고, 상기 NaCl의 함량은 0.75%(w/v) 내지 2.75%(w/v), 바람직하게는 0.75%(w/v) 내지 1.25%(w/v) 또는 2.25%(w/v) 내지 2.75%(w/v)인 조건에서 배양할 수 있다.The MJ bacterium HJM27 (KCTC 11680BP) is an alginate degrading enzyme producing strain that has been found to have excellent alginate degrading activity, and the growth rate was sharply lowered when the concentration of NaCl in the medium was 2.5%. (halotolerant stain). According to the results confirmed, the MJ bacterium HJM27 (KCTC 11680BP), the NaCl content in the medium is expressed as a concentration relative to the weight of NaCl relative to the volume of the total composition (NaCl content (w) / total medium volume (v) NaCl content is 0.75% (w / v) to 2.75% (w / v), preferably 0.75% (w / v) to 1.25% (w / v) or 2.25% (w) / v) to 2.75% (w / v).
상기 메틸로박테리움 속 HJM27(KCTC 11680BP)은 통상의 배지, 일 예로 질소원이 포함된 통상의 배지에서 배양할 수 있으며, 바람직하게는 효모 추출물(Yeast Extracct) 및 펩톤(peptone)이 포함된 배지에서 배양할 수 있다. 상기 효모 추출물은 천연첨가물로, 효모 세포의 성분인 아미노산(amino acids), 펩타이드(peptides), 탄수화물(carbohydrates) 및 염류와 같은 수용성 성분으로 이루어져 있다. 상기 효모 추출물은 식용 효모에 식용이 가능한 효소류을 첨가하여, 식용 효모의 폴리펩타이드를 가수분해하는 방법으로 만들며, 제조 과정에서 추가로 염류를 첨가할 수 있다. 상기 펩톤은 산 · 알칼리 또는 단백질분해효소나 펩티다아제에 의해 분해된 분해산물인 유도단백질로, 단백질의 펩신에 의한 분해산물을 포함한다. 상기 펩톤은 단백질 분해산물 중 프로테오스보다 저분자로, 수용성이며 열에 응고되지 않는다.The MJ bacterium HJM27 (KCTC 11680BP) can be cultured in a conventional medium, for example a conventional medium containing a nitrogen source, preferably in a medium containing yeast extract (Yeast Extracct) and peptone (peptone) Can be cultured. The yeast extract is a natural additive and consists of water-soluble components such as amino acids, peptides, carbohydrates, and salts, which are components of the yeast cell. The yeast extract is made by adding edible enzymes to the edible yeast, a method of hydrolyzing the polypeptide of the edible yeast, it can be added to the salt in the manufacturing process. The peptone is an inducible protein that is an acid, an alkali, or a degradation product decomposed by a protease or peptidase, and includes a degradation product of pepsin of a protein. The peptone is a lower molecule than proteases in the proteolytic products, is water soluble and does not coagulate with heat.
또한, 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)은 알긴산이 첨가되지 않은 배지 또는 알긴산이 첨가된 배지에서 배양할 수 있다.In addition, the MJ bacterium HJM27 (KCTC 11680BP) can be cultured in a medium to which no alginic acid is added or a medium to which alginic acid is added.
상기 메틸로박테리움 속 HJM27(KCTC 11680BP)은 알긴산 분해효소를 생산할 수 있다. 상기 메틸로박테리움 속 HJM27(KCTC 11680BP) 또는 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)가 생성한 분해효소의 최적반응 온도는 25℃이고, 상기 메틸로박테리움 속 HJM27(KCTC 11680BP) 또는 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)가 생성한 분해효소의 최적반응 pH는 pH 9.0이며, 중성과 약알카리성 범위에서 높은 활성을 유지할 수 있다. 또한, 상기 메틸로박테리움 속 HJM27(KCTC 11680BP) 또는 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)가 생성한 분해효소의 최적반응 NaCl의 농도는 1.25%(w/v) 내지 1.75%(w/v), 바람직하게는 1.4%(w/v) 내지 1.6%(w/v)일 수 있다.The genus HJM27 (KCTC 11680BP) may produce alginate degrading enzymes. The optimum reaction temperature of the degrading enzyme produced by HJM27 (KCTC 11680BP) or Methylbacterium HJM27 (KCTC 11680BP) is 25 ° C., and HJM27 (KCTC 11680BP) or Methylbacterium The optimum reaction pH of the degrading enzyme produced by HJM27 (KCTC 11680BP) in Methylbacterium is pH 9.0, and can maintain high activity in the neutral and weak alkaline range. In addition, the concentration of the optimal reaction NaCl of the degrading enzyme produced by the HJM27 (KCTC 11680BP) genus Methylbacterium or HJM27 (KCTC 11680BP) genus is 1.25% (w / v) to 1.75% (w / v), preferably from 1.4% (w / v) to 1.6% (w / v).
또한, 본 발명은 알긴산 분해능을 갖는 생촉매(biocatalyst)에 관한 것이다.The present invention also relates to a biocatalyst having alginic acid resolution.
상기 알긴산 분해능을 갖는 생촉매는 상기 메틸로박테리움 속 균주, 바람직하게는 메틸로박테리움 속 HJM27(KCTC 11680BP), 상기 균주의 배양물 및 상기 배양물의 농축물으로 이루어진 군에서 선택된 1종 이상을 포함하는 것일 수 있다.The biocatalyst having the alginic acid resolution may be at least one selected from the group consisting of the strain of the genus Methylobacterium, preferably HJM27 (KCTC 11680BP) of the genus Methylbacterium, the culture of the strain and the concentrate of the culture. It may be to include.
상기 균주의 배양물이란 메틸로박테리움 속 HJM27(KCTC 11680BP)을 배양하여 얻어진 배양배지를 의미하며, 상기 균주가 포함되어 있는 배양배지 또는 상기 균체를 제거한(cell-free) 무세포 배양배지일 수 있다. 상기 균주의 배양물이란 액상의 배양배지에 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)을 배양한 후, 얻어진 배양배지일 수 있으나, 상기 배양물의 성상이 액체 또는 고체로 한정되는 것은 아니다.The culture of the strain means a culture medium obtained by culturing HJM27 (KCTC 11680BP) in Methylbacterium, and may be a culture medium containing the strain or a cell-free culture medium in which the cells are removed. have. The culture of the strain may be a culture medium obtained after culturing the MJ bacterium HJM27 (KCTC 11680BP) in a liquid culture medium, but the nature of the culture is not limited to liquid or solid.
상기 배양배지는 미생물이나 동식물의 조직을 배양하기 위한 통상의 배지일 수 있으며, 바람직하게는 효모 추출물(Yeast Extracct) 및 펩톤(peptone)으로 이루어진 군중에서 선택된 1종 이상이 더욱 포함된 것일 수 있고, 더욱 바람직하게는 효모 추출물(Yeast Extracct) 및 펩톤(peptone)이 포함된 것일 수 있다.The culture medium may be a conventional medium for culturing the tissues of microorganisms or animals, preferably one or more selected from the group consisting of yeast extract (Yeast Extracct) and peptone (peptone) may be further included, More preferably, yeast extract (Yeast Extracct) and peptone (peptone) may be included.
또한, 상기 배양배지에는 알긴산이 첨가될 수 있으며, 상기 알긴산의 함량은 전체 배지 부피 대비 알긴산의 함량을 기준으로 0.4%(w/v) 내지 1.25%(w/v), 바람직하게는 0.85%(w/v) 내지 1.15%(w/v), 더욱 바람직하게는 0.9%(w/v) 내지 1.1%(w/v)일 수 있다.In addition, alginic acid may be added to the culture medium, and the content of alginic acid is 0.4% (w / v) to 1.25% (w / v), preferably 0.85% (based on the content of alginic acid relative to the total medium volume). w / v) to 1.15% (w / v), more preferably 0.9% (w / v) to 1.1% (w / v).
또한, 상기 배양배지의 NaCl 함량은 전체 배지 부피 대비 NaCl의 함량을 기준으로 0.75%(w/v) 내지 2.75%(w/v), 바람직하게는 0.75%(w/v) 내지 1.75%(w/v) 또는 2.25%(w/v) 내지 2.75%(w/v), 더욱 바람직하게는 1.25%(w/v) 내지 1.75%(w/v), 더더욱 바람직하게는 1.4%(w/v) 내지 1.6%(w/v)일 수 있다.In addition, the NaCl content of the culture medium is 0.75% (w / v) to 2.75% (w / v), preferably 0.75% (w / v) to 1.75% (w) based on the content of NaCl relative to the total medium volume. / v) or 2.25% (w / v) to 2.75% (w / v), more preferably 1.25% (w / v) to 1.75% (w / v), even more preferably 1.4% (w / v) ) To 1.6% (w / v).
상기 배양물의 농축물이란 상기 균주의 배양물을 통상적인 방법으로 하여 농축한 것을 의미한다. 상기 배양물의 농축물은 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)을 배양한 액상의 배양배지를 통상의 방법으로 농축한 농축액일 수 있으나, 상기 배양물의 성상이 액체로 한정되는 것은 아니다.The concentrate of the culture means that the culture of the strain is concentrated in a conventional manner. The concentrate of the culture may be a concentrate of a liquid culture medium in which the culture of HJM27 (KCTC 11680BP) in the methylobacterium is concentrated in a conventional manner, but the nature of the culture is not limited to liquid.
또한, 본 발명은 상기 알긴산 분해능을 갖는 생촉매를 제조하는 제조방법에 관한 것이다.The present invention also relates to a production method for producing a biocatalyst having the alginic acid resolution.
상기 생촉매 제조방법은 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)을 배지에 배양하는 단계를 포함하는 것일 수 있다.The biocatalyst manufacturing method may include culturing the MJ bacterium HJM27 (KCTC 11680BP) in a medium.
보다 구체적으로, 상기 생촉매 제조방법은 상기 효모 추출물 및 상기 펩톤이 포함된 배지에서 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)을 배양하는 단계를 포함하는 것일 수 있다.More specifically, the biocatalyst manufacturing method may include culturing the MJ bacterium HJM27 (KCTC 11680BP) in a medium containing the yeast extract and the peptone.
상기 효모 추출물 및 상기 펩톤이 포함된 배지의 NaCl 함량은 0.75%(w/v) 내지 2.75%(w/v), 바람직하게는 0.75%(w/v) 내지 1.75%(w/v) 또는 2.25%(w/v) 내지 2.75%(w/v), 더욱 바람직하게는 1.25%(w/v) 내지 1.75%(w/v), 더더욱 바람직하게는 1.4%(w/v) 내지 1.6%(w/v)일 수 있다.NaCl content of the yeast extract and the medium containing the peptone is 0.75% (w / v) to 2.75% (w / v), preferably 0.75% (w / v) to 1.75% (w / v) or 2.25 % (w / v) to 2.75% (w / v), more preferably 1.25% (w / v) to 1.75% (w / v), even more preferably 1.4% (w / v) to 1.6% ( w / v).
상기 배지의 알긴산 함량은 전제 배지 부피 대비 알긴산 중량을 기준으로 0.4%(w/v) 내지 1.25%(w/v), 바람직하게는 0.85%(w/v) 내지 1.15%(w/v), 더욱 바람직하게는 0.9%(w/v) 내지 1.1%(w/v)일 수 있다.The alginic acid content of the medium is 0.4% (w / v) to 1.25% (w / v), preferably 0.85% (w / v) to 1.15% (w / v), based on the weight of alginic acid relative to the total medium volume, More preferably, it may be 0.9% (w / v) to 1.1% (w / v).
상기 배양배지에서 상기 메틸로박테리움 속 HJM27(KCTC 11680BP)를 배양하는 단계는 36시간 내지 60시간, 바람직하게는 42시간 내지 54시간 더욱 바람직하게는 45시간 내지 51시간 동안 수행할 수 있다.The step of culturing the MJ bacterium HJM27 (KCTC 11680BP) in the culture medium may be carried out for 36 hours to 60 hours, preferably 42 hours to 54 hours, more preferably 45 hours to 51 hours.
또한, 본 발명은 상기 알긴산 분해능을 갖는 생촉매를 이용하여 알긴산 올리고머를 제조하는 제조방법에 관한 것이다.The present invention also relates to a method for producing an alginic acid oligomer using the biocatalyst having the alginic acid resolution.
상기 제조방법은 상기 알긴산 분해능을 갖는 생촉매를 해조류 및 알긴산으로 이루어진 군 중에서 선택된 1종 이상과 반응시키는 단계를 포함하는 것일 수 있다.The manufacturing method may include reacting the biocatalyst having the alginic acid resolution with at least one selected from the group consisting of algae and alginic acid.
상기 해조류(sea algae)는 바다에서 나는 조류를 통틀어 이르는 말로 통상의 조류를 포함한다. 상기 해조류는 녹조류(green algae), 갈조류(brown algae) 및 홍조류(red algae)로 이루어진 군 중에서 선택된 1종 이상을 포함하는 것으로, 바람직하게는 갈조류일 수 있다. 상기 갈조류는 일 예로 톳, 미역, 다시마, 대황 또는 모자반일 수 있으나, 이에 한정되는 것은 아니다. 상기 알긴산 올리고머는 알긴산이 분해된 통상의 알긴산 올리고머일 수 있으며, 일 예로 폴리글루론산 블록, 폴리만뉴론산 블록, 폴리글루론산-폴리만뉴론산 블록 또는 상기 폴리글루론산 블록, 폴리만뉴론산 블록 및 폴리글루론산-폴리만뉴론산 블록으로 이루어진 군 중에서 선택된 1종 이상이 결합된 당중합체일 수 있다.The sea algae is a word that refers to algae flying in the sea and includes a conventional algae. The algae includes at least one selected from the group consisting of green algae, brown algae, and red algae, and may be preferably brown algae. The brown algae may be, for example, 톳, wakame seaweed, kelp, rhubarb, or maban, but is not limited thereto. The alginic acid oligomer may be a common alginic acid oligomer from which alginic acid is decomposed, and for example, polygluronic acid block, polymanneuronic acid block, polygluronic acid-polymanneuronic acid block, or the polygluronic acid block, polymanneuronic acid block. And it may be a sugar polymer to which at least one selected from the group consisting of polygluronic acid-polymanneuronic acid block is bonded.
상기 제조방법은 23℃ 내지 27℃, 바람직하게는 24℃ 내지 26℃할 수 있고, 더욱 바람직하게는 25℃에서 수행할 수 있으며, 상기 제조방법은 pH 7.5 내지 pH 11, 바람직하게는 pH 8 내지 pH 10, 더욱 바람직하게는 pH 8.5 내지 pH 9.5에서 수행할 수 있다.The preparation method may be performed at 23 ° C. to 27 ° C., preferably 24 ° C. to 26 ° C., more preferably at 25 ° C., and the preparation method may be pH 7.5 to
상기 해조류의 함량은 반응액 전체 부피 대비 해조류에 포함된 알긴산의 중량을 기준으로 0.15%(w/v) 내지 1.25%(w/v), 바람직하게는 0.35%(w/v) 내지 1.15%(w/v), 더욱 바람직하게는 0.5%(w/v) 내지 1.0%(w/v)일 수 있고, 상기 알긴산의 함량은 반응액 전체 부피 대비 알긴산의 중량을 기준으로 0.15%(w/v) 내지 1.25%(w/v), 바람직하게는 0.35%(w/v) 내지 1.15%(w/v), 더욱 바람직하게는 0.5%(w/v) 내지 1.0%(w/v)일 수 있다.The content of the seaweed is 0.15% (w / v) to 1.25% (w / v), preferably 0.35% (w / v) to 1.15% (based on the weight of the alginic acid included in the seaweed relative to the total volume of the reaction solution). w / v), more preferably 0.5% (w / v) to 1.0% (w / v), and the content of the alginic acid is 0.15% (w / v based on the weight of the alginic acid relative to the total volume of the reaction solution). ) To 1.25% (w / v), preferably 0.35% (w / v) to 1.15% (w / v), more preferably 0.5% (w / v) to 1.0% (w / v) have.
본 발명의 메틸로박테리움 속 HJM27(KCTC 11680BP)은 기존 보고된 알긴산 분해능을 가진 다른 미생물에 비하여 현저하게 우수한 활성을 나타내고, 특정 배양 조건 및 특정 반응 조건에 따라 최적의 반응 수율을 얻을 수 있으므로 새로운 생촉매로서 유용하게 사용되어질 것으로 예상되고, 특히 의약품 및 기능성 식품과 관련된 산업에 크게 기여할 수 있을 것으로 예상된다.Methylbacterium genus HJM27 (KCTC 11680BP) of the present invention shows a remarkably superior activity compared to other microorganisms with the previously reported alginic acid resolution, it is possible to obtain the optimum reaction yield according to specific culture conditions and specific reaction conditions It is expected to be usefully used as a biocatalyst, and it is expected to contribute greatly to industries related to pharmaceuticals and functional foods.
이상 살펴본 바와 같이, 본 발명에 따른 메틸로박테리움 속 HJM27(KCTC 11680BP)은 기존 보고된 알긴산 분해능을 갖는 다른 미생물에 비하여 현저하게 우수한 알긴산 분해능이 인정되어, 알긴산을 분해하여 인류의 건강 및 질병 치료 등과 관련된 다양한 기능성을 가진 고부가가치 상품인 다양한 알긴산 올리고머을 제조할 수 있을 뿐만 아니라, 해조류를 이용한 바이오에너지 생산과 관련하여, 해조류의 세포벽의 주요성분을 분해함으로써 바이오에너지 생산 효율의 증대가 가능하다는 점에서 의약품 및 기능성 식품과 관련된 산업을 포함한 다양한 산업에서 그 산업적 이용가치가 매우 크다고 할 수 있다.As described above, HJM27 (KCTC 11680BP) of the genus Methylobacterium according to the present invention is remarkably excellent alginate resolution compared to other microorganisms having the previously reported alginic acid resolution, decomposing alginic acid to treat human health and disease In addition to producing a variety of alginate oligomers, which are high value-added products with various functionalities, etc., in addition to the bioenergy production using seaweeds, it is possible to increase the efficiency of bioenergy production by decomposing the main components of the cell walls of seaweeds. The value of industrial use is very high in various industries, including those related to pharmaceuticals and functional foods.
도 1은 본 발명의 일 실시예에 따른, 메틸로박테리움 속 HJM27(Methylobacterium sp. HJM27)의 16S rDNA의 염기서열이다.
도 2는 본 발명의 일 실시예에 따른, 메틸로박테리움 속 HJM27의 16S rDNA의 염기서열을 기초로 한 다른 세균과의 계통발생론적 관계를 나타내는 도이다. 상기 도 2의 균주 종에 관한 기재 옆에 있는 <>안에 기재된 번호는 NCBI 데이터베이스(NCBI database)의 기탁번호(accession number)이다.
도 3은 본 발명의 일 실시예에 따른, 질소원에 따른 메틸로박테리움 속 HJM27의 균체 생장(Cell growth) 정도 및 균체 당 알긴산 분해능(relative activity)을 나타내는 그래프이다. 상기 균체 생장 정도는 직선 그래프(line)로 표시되고, OD600을 표시한 우측 수치를 기준으로 나타내며, 상기 당 알긴산 분해능은 막대그래프(bar)로 표시되고, 최적 활성을 나타낸 군(펩톤(peptone) 첨가군)을 기준으로 한 상대 활성을 표시하는 좌측 수치로 나타낸다.
도 4는 본 발명의 일 실시예에 따른, 펩톤 및 효모 추출물 첨가에 따른 메틸로박테리움 속 HJM27의 균체 생장 정도 및 균체 당 알긴산 분해능을 나타내는 그래프이다. 상기 균체 생장 정도는 직선 그래프(line)로 표시되고, OD600을 표시한 우측 수치를 기준으로 나타내며, 상기 당 알긴산 분해능은 막대그래프(bar)로 표시되고, 최적 활성을 나타낸 군(펩톤 및 효모 추출물 첨가군, PSY medium)을 기준으로 한 상대 활성을 표시하는 좌측 수치로 나타낸다. 백색 막대 및 백색 직선 그래프는 펩톤을 첨가한 군(PS medium)을 나타내고, 흑색 막대 및 흑색 직선 그래프는 펩톤 및 효모 추출물을 첨가한 군(PSY medium)을 나타낸다.
도 5는 본 발명의 일 실시예에 따른, 알긴산 첨가량에 따른 메틸로박테리움 속 HJM27의 균체 생장 정도 및 균체 당 알긴산 분해능을 나타내는 그래프이다. 상기 균체 생장 정도는 직선 그래프(line)로 표시되고, OD600을 표시한 우측 수치를 기준으로 나타내며, 상기 당 알긴산 분해능은 막대그래프(bar)로 표시되고, 최적 활성을 나타낸 군(알긴산 첨가량이 1.0%(w/v)인 첨가군)을 기준으로 한 상대 활성을 표시하는 좌측 수치로 나타낸다.
도 6은 본 발명의 일 실시예에 따른, 메틸로박테리움 속 HJM27이 생산하는 생촉매의 온도에 따른 알긴산 분해능을 나타낸 그래프이다.
도 7은 본 발명의 일 실시예에 따른, 메틸로박테리움 속 HJM27이 생산하는 생촉매의 pH에 따른 알긴산 분해능을 나타낸 그래프이다.Figure 1 is a nucleotide sequence of 16S rDNA of, tumefaciens in HJM27 (Methylobacterium sp. HJM27) methyl, according to one embodiment of the present invention.
Figure 2 is a diagram showing a phylogenetic relationship with other bacteria based on the nucleotide sequence of 16S rDNA of the genus HJM27 according to an embodiment of the present invention. The number in <> next to the description about the strain species of FIG. 2 is an accession number of NCBI database.
FIG. 3 is a graph showing the degree of cell growth and relative activity of alginic acid per cell according to the nitrogen source of HJM27 in Methylbacterium according to the nitrogen source. The growth rate of the cells is represented by a straight line (line), based on the right value indicated OD 600 , the sugar alginic acid resolution is represented by a bar graph (bar), the group showing the optimal activity (peptone) It is shown by the left figure which shows the relative activity based on the addition group).
Figure 4 is a graph showing the growth rate of the cell growth and alginate degradation per cell of the genus HJM27 according to the peptone and yeast extract according to an embodiment of the present invention. The growth rate of the cells is represented by a straight line (line), based on the right value indicated OD 600 , the sugar alginic acid resolution is represented by a bar graph (bar), the group showing the optimum activity (peptone and yeast extract It is shown by the left figure which shows the relative activity based on the addition group, PSY medium). White bars and white straight line graphs show the group added with peptone (PS medium), black bars and black straight line graphs show the group added with peptone and yeast extract (PSY medium).
FIG. 5 is a graph showing the growth rate of cells and alginate resolution per cell of MJ bacterium HJM27 according to the amount of alginic acid added according to an embodiment of the present invention. The growth rate of the cells is represented by a straight line (line), based on the right value of OD 600 , the sugar alginic acid resolution is represented by a bar graph (bar), the group showing the optimum activity (alginate addition amount 1.0 the relative activity based on% (w / v)).
Figure 6 is a graph showing the alginic acid resolution according to the temperature of the biocatalyst produced by the genus HJM27 in methyllobacterium according to an embodiment of the present invention.
7 is a graph showing the alginic acid resolution according to the pH of the biocatalyst produced by the genus HJM27 in Methylbacterium according to an embodiment of the present invention.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily practice the present invention. As those skilled in the art would realize, the described embodiments may be modified in various different ways, all without departing from the spirit or scope of the present invention.
[실시예][Example]
<실시예 1> 알긴산 분해능을 갖는 해양 미생물의 탐색 및 분리Example 1 Screening and Isolation of Marine Microorganisms Having Alginic Acid Resolution
알긴산 분해능을 갖는 미생물의 분리를 위한 시료는 2009년 5월에 대한민국 부산광역시 기장군 기장읍 대변항과 경상남도 통영에서 구입한 해양 동물인 전복(Haliotis discus hannai), 소라(Batillus cornutus), 해삼(Stichopus japonicus), 멍게(Halocynthia roretzi) 및 개불(Urechis unicinctus)를 이용하여 제조하였다. 보다 구체적으로, 상기 시료는 상기 해양 동물의 내장을 분리한 후, 상기 분리된 내장을 잘게 잘라서 멸균된 희석액(NaCl 2.5 g, KH2PO4 0.1 g, FeSO4·7H2O 0.05 g, KCl 0.05 g, NH4Cl 0.1 g, 증류수 1L, pH 7)을 이용하여 연속 희석하는 방법으로 1,000배 희석하여 제조하였다.The sample for the isolation of microorganisms with alginate resolution was Haliotis , a marine animal purchased from Daebyeon Port and Gijang-eup, Gijang-gun, Busan, Korea in May 2009. discus hannai ), hermit ( Batillus) cornutus ), sea cucumber ( Stichopus japonicus ), sea urchin ( Halocynthia) roretzi ) and Gaeul ( Urechis unicinctus ) were prepared. More specifically, the sample is separated from the viscera of the marine animal, and then chopped the separated viscera sterilized diluent (NaCl 2.5 g, KH 2 PO 4 0.1 g, FeSO 4 · 7H 2 O 0.05 g, KCl 0.05 g, NH 4 Cl 0.1 g, distilled water 1L, pH 7) was prepared by diluting 1,000 times by a continuous dilution method.
상기 해양 동물의 내장으로부터 제조된 시료를 이용한 알긴산 분해능을 갖는 미생물의 분리는 2단계로 진행되었다.Separation of microorganisms having alginic acid resolution using a sample prepared from the intestine of the marine animal proceeded in two steps.
보다 상세하게는, 상기 알긴산 분해능을 갖는 미생물의 탐색은 1차로 상기 1,000배 희석한 시료액 0.1 mL를 다층평판배지 위에 도말하여 알긴산 분해능을 확인하는 방법으로 수행하였다. 상기 다층평판배지는 하층배지와 상층배지의 2층으로 구성되고, 상기 하층배지(pH 7)의 조성은 전체 배지 조성물 부피 대비 각 성분이 NaCl 2.5%(w/v), KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), NH4Cl 0.1%(w/v) 및 agar 2.0%(w/v)의 함량으로 구성되어있고, 상기 상층배지(pH 7)의 조성은 전체 배지 조성물 부피 대비 sodium alginate 1.0%(w/v) 및 agar 2.0%(w/v)의 함량으로 구성되어 있다. 상기 1,000배 희석된 시료 0.1 mL를 상기 다층평판배지 위에 도말하고, 25℃에서 3일간 배양한 후, 형성된 세균군체(colony)들 중에서 군체 크기가 1 mm 이상인 균주를 백금이를 이용하여 채취한 후에, 새로운 다층평판배지위에 도말하는 것을 수차례 반복하여 분리하는 방법으로, 균체를 순수 분리하였다.More specifically, the search for the microorganism having the alginic acid resolution was carried out by a method of confirming the alginic acid resolution by first plating 0.1 mL of the sample solution diluted 1,000-fold on the multilayer plate medium. The multi-layered flat medium is composed of two layers of a lower medium and an upper medium, and the composition of the lower medium (pH 7) is 2.5% (w / v) of NaCl, 0.1% of KH 2 PO 4 , and the composition of the total medium composition. (w / v), FeSO 4 .7H 2 O 0.05% (w / v), KCl 0.05% (w / v), NH 4 Cl 0.1% (w / v) and agar 2.0% (w / v) The composition of the upper medium (pH 7) is composed of the content of sodium alginate 1.0% (w / v) and agar 2.0% (w / v) relative to the total medium composition volume. 0.1 mL of the 1,000-fold diluted sample was plated on the multi-layered plate medium, incubated at 25 ° C. for 3 days, and then a strain having a colony size of 1 mm or more was collected using platinum teeth among the colonies formed. Cells were purified purely by the method of separating several times repeatedly by smearing onto a new multilayer plate medium.
상기 배양 결과, 약 5 만개의 콜로니가 분리배지 위에서 성장하는 것이 확인되었고, 이 중 군체 크기가 1 mm 이상이어서 알긴산 분해능이 우수한 것으로 판단된 균주에 대해서 알긴산 분해능의 정도를 확인하였다.As a result of the culture, it was confirmed that about 50,000 colonies were grown on the separation medium, and the degree of alginic acid resolution was confirmed for the strain determined to have excellent alginate resolution because the colony size was 1 mm or more.
상기 균주를 순수 분리하는 1단계를 수행한 후, 2차로 상기 순수 분리된 균체의 알긴산 분해능을 확인하는 방법으로 알긴산 분해능이 가장 우수한 균주를 분리하였다. 상기 알긴산 분해능이 우수한 균주의 분리를 위한 알긴산 분해능의 확인은 plate assay 법과 DNS 법으로 수행하였다.After performing the first step of purely separating the strain, the second strain was isolated the most excellent alginate resolution by checking the alginate resolution of the purely isolated cells. Confirmation of alginic acid resolution for isolation of the strain having excellent alginic acid resolution was performed by plate assay and DNS method.
보다 구체적으로, 우선 1단계에서 순수 분리된 균주들을 배양하였다. 상기 배양은 상기 순수 분리된 균주를 PYS 배지(peptone 0.5%(w/v), yeast extract 0.3%(w/v), sodium alginate 1.0%(w/v), NaCl 1.5%(w/v), pH 7)에 접종하고, 25℃ 및 150 rpm의 조건으로 24시간 진탕 배양하는 방법으로 수행하였다.More specifically, in the first step, purely isolated strains were cultured. The culture of the pure strain isolated PYS medium (peptone 0.5% (w / v), yeast extract 0.3% (w / v), sodium alginate 1.0% (w / v), NaCl 1.5% (w / v), inoculated at pH 7) and shake cultured at 25 ° C. and 150 rpm for 24 hours.
상기 알긴산 분해능의 1차 확인은 plate assay 법으로 수행하였다. 상기 plate assay 법은 다음과 같은 방법으로 수행하였다. 우선, 알긴산 분해능 확인용 PS 한천배지(peptone 0.5%(w/v), sodium alginate 0.8%(w/v), agar 1.5%(w/v))에 상기 24시간 진탕 배양한 균주 30 μL를 점적하고 25℃에서 2일간 정치 배양하였다. 이후 균주가 자란 배지에 배지가 잠길 정도로 10% CPC(cetylpyridinium chloride monohydrate)를 투여하였고, 10분 후 알긴산 분해효소의 활성을 확인하였다. 상기 방법에 의하여 약 27종의 콜로니로부터 분리한 균주가 1차 우수 균주로 선정되었다.The first confirmation of the alginic acid resolution was performed by plate assay method. The plate assay was performed in the following manner. First, 30 μL of the strain cultured on the above 24 hours shaken in PS agar medium (peptone 0.5% (w / v), sodium alginate 0.8% (w / v), agar 1.5% (w / v)) for checking alginic acid resolution. And it was incubated for 2 days at 25 ℃. Thereafter, 10% CPC (cetylpyridinium chloride monohydrate) was administered to the medium in which the strain was grown, and 10 minutes later, the activity of alginic acid degrading enzyme was confirmed. The strain isolated from about 27 colonies by this method was selected as the first excellent strain.
상기 알긴산 분해능의 2차 확인은 상기 1차 우수 균주로 선정된 균주를 대상으로 DNS법으로 수행하였다. 상기 DNS법은 환원당 생성능을 확인하는 방법으로, 다음과 같은 방법으로 수행하였다. 상기 PYS 배지(peptone 0.5%(w/v), yeast extract 0.3%(w/v), sodium alginate 1.0%(w/v), NaCl 1.5%(w/v), pH 7)에 1차 우수 균주로 선정된 27종의 균주를 접종하고, 25℃ 및 150 rpm의 조건으로 진탕 배양하면서, 시간별로 환원당 생성능을 측정하였다. 상기 환원당 생성능의 측정을 위한 환원당 함량은 DNS법을 이용하였고, 실험방법은 다음과 같은 방법으로 수행하였다. 우선, 상기 일정 시간동안 배양한 배양액을 14,000×g 및 4℃의 조건에서 5분간 원심분리하고, 분리된 상층액을 수득하였고, 상기 수득된 상층액을 조효소액으로 사용하였다. sodium alginate(0.8%)가 포함된 기질용액 1.0 mL에 상기 조효소액 500 μL를 혼합한 후, 30분 동안 항온조에서 150 rpm 및 25℃의 반응 조건으로 반응 시킨 후, 반응액을 14,000×g 및 4℃의 조건에서 5분간 원심분리하였다. 상기 원심분리하여 분리된 상층액 500 μL 에 DNS용액 2 mL을 가한 후, 10분간 가열하였고, 540 nm에서 흡광도를 측정하였다. 상기 측정된 흡광도 결과로부터 Mannuronic acid를 이용하여 작성한 표준 검량선을 이용하여 생성된 환원당을 정량 하였고, 환원당 생성능이 알긴산 분해효소 활성에 비례하는 것으로 확인하였다.The second confirmation of the alginic acid resolution was performed by the DNS method for the strain selected as the first excellent strain. The DNS method is a method for confirming reducing sugar generating ability, and was performed in the following manner. Primary excellent strain in the PYS medium (peptone 0.5% (w / v), yeast extract 0.3% (w / v), sodium alginate 1.0% (w / v), NaCl 1.5% (w / v), pH 7) Inoculated with 27 strains selected as, shaking culture under conditions of 25 ℃ and 150 rpm, reducing sugar production capacity was measured by time. The reducing sugar content for measuring the reducing sugar generation capacity was used by the DNS method, the experimental method was carried out in the following manner. First, the culture broth cultured for a predetermined time was centrifuged for 5 minutes under conditions of 14,000 × g and 4 ° C., and the separated supernatant was obtained, and the obtained supernatant was used as a coenzyme solution. 500 μL of the coenzyme solution was mixed with 1.0 mL of a substrate solution containing sodium alginate (0.8%), followed by reaction at 150 rpm and 25 ° C. in a thermostat for 30 minutes, and then the reaction solution was 14,000 × g and 4 It was centrifuged for 5 minutes at the conditions of ° C. 500 mL of the supernatant separated by centrifugation was added 2 mL of DNS solution, and then heated for 10 minutes, and the absorbance was measured at 540 nm. From the measured absorbance results, the reducing sugar produced was quantified using a standard calibration curve prepared using Mannuronic acid, and it was confirmed that the reducing sugar producing ability was proportional to the alginic acid enzyme activity.
상기 확인결과, 가장 환원당 생성능이 우수한 즉, 알긴산 분해능이 우수한 균주로 전복 내장에서 분리한 균주인 HJM27이 최종적으로 선정되었다.
As a result of the above, HJM27, which was isolated from abalone viscera, was finally selected as a strain having the best reducing sugar production ability, that is, the alginate resolution.
<< 실시예Example 2> 알긴산 분해능을 갖는 해양 미생물 2> Marine microorganisms with alginic acid resolution HJM27HJM27 의 동정The identification of
상기 2차 측정에서 가장 우수한 분해능을 나타내어 최종 선정된 HJM27 균주의 동정은 16S rDNA 염기서열분석법으로 수행하였다. 16S rDNA 염기서열 분석을 위한 상기 HJM27 균주의 서열확인은 (주)마크로젠(대한민국)에 의뢰하여 수행하였다. 상기 (주)마크로젠에 의뢰결과로 확인된 HJM27 균주의 16S rDNA는 도 1에 나타낸 바와 같이, 총 1,411 base pair(bp) 염기서열이 결정되었다.Identification of the best selected HJM27 strain showing the best resolution in the second measurement was performed by 16S rDNA sequencing. Sequencing of the HJM27 strain for 16S rDNA sequencing was performed by requesting Macrogen (Korea). 16S rDNA of the HJM27 strain confirmed as a result of the request by Macrogen Co., Ltd. as shown in Figure 1, a total of 1,411 base pair (bp) base sequence was determined.
상기 결정된 HJM27 균주의 16S rDNA의 서열분석은 GenBank에 등록된 정보를 대상으로 NCBI의 Blast program(http://www. ncbi.nlm. nih.gov/BLAST/Blast.cgi)에 의해 상동성 검색을 실시하고, Clustal 프로그램(Clustal X ver. 1.8)을 이용하여 다중염기배열(multiple alignment)을 수행한 후, neighbor-joining method와 bootstrap method(n=1,000)로 분석하여 계통분류학적 위치를 파악하여, 그 결과를 계통 발생도(Phylogenetic tree)로 작성하였으며, 그 결과를 도 2에 나타내었다.The sequencing of the 16S rDNA of the determined HJM27 strain was performed for homology search by NCBI's Blast program (http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi) based on the information registered in GenBank. After multiple alignments are performed using the Clustal program (Clustal X ver. 1.8), the phylogenetic location is determined by analyzing the neighbor-joining method and the bootstrap method (n = 1,000). The results were prepared in a phylogenetic tree, and the results are shown in FIG. 2.
상기 도 2에 나타낸 바와 같이, 분리균주 HJM27은 알파프로박테리아(alpha-proteobacteria)에 속하는 메틸로박테리움 속 균주(NCBI accesision #; EU741082)와 99%의 유사성을 보였다. 상기 분리균주 HJM27은 메틸로박테리움 속 균주와 높은 유사성을 나타내어, HJM27은 메틸로박테리움 속 균주(Methylobacterium sp.)로 최종 동정되었으며, 메틸로박테리움 속 HJM27(Methylobacterium sp. HJM27)로 명명하였다.As shown in FIG. 2, the isolated strain HJM27 showed 99% similarity to the strain of the genus Methylobacterium (NCBI accesision #; EU741082) belonging to alpha-proteobacteria. The strain HJM27 exhibits a tumefaciens sp with a high affinity to methyl, HJM27 was the final identified as tumefaciens sp (Methylobacterium sp.) With methyl, was named tumefaciens in HJM27 (Methylobacterium sp. HJM27) methyl .
상기 메틸로박테리움 속 HJM27은 대한민국 대전광역시 유성구에 위치한 생물자원센터에 2010년 4월 13일자로 기탁되어 기탁번호 KCTC 11680BP를 부여받았다.
HJM27 in the methylobacterium was deposited on April 13, 2010 at the Biological Resource Center located in Yuseong-gu, Daejeon, Korea, and received the accession number KCTC 11680BP.
<< 실시예Example 3> 3> 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 이 생산하는 알긴산 분해효소의 특성Characteristics of Alginate Degrading Enzymes
상기 분리 및 동정된 메틸로박테리움 속 HJM27의 배양 조건에 따른 생육 정도, 즉 균주 증식능 및 상기 메틸로박테리움 속 HJM27이 생산하는 알긴산 분해효소의 반응 조건에 따른 효소 활성을 확인하기 위하여, 상기 메틸로박테리움 속 HJM27을 배양하였다. 상기 배양을 위한 배양배지의 조성은 기본적으로 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v) 및 agar 2.0%(w/v)의 함량으로 구성되고, 배양을 통해 확인하고자 하는 것에 따라 질소원(효모 추출물, 펩톤, NH4Cl, 요소(urea) 및 (NH4)2SO4), sodium alginate 및 NaCl의 첨가여부 또는 함량을 조절하였다.In order to confirm the extent of growth according to the culture conditions of the isolated and identified Methylbacterium genus HJM27, that is, the strain propagation ability and the enzyme activity according to the reaction conditions of the alginic acid degrading enzyme produced by the Methylbacterium genus HJM27, Lobacterium spp. HJM27 was cultured. The composition of the culture medium for the culture is basically 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 · 7H 2 O, 0.05% (w / v) of KCl and 2.0% of agar ( w / v) and the addition of nitrogen sources (yeast extract, peptone, NH 4 Cl, urea and (NH 4 ) 2 SO 4 ), sodium alginate and NaCl depending on the culture Or the content was adjusted.
구체적으로, 우선 상기 균주의 배양배지와 관련하여 질소원에 따른 균주 증식능 및 효소 활성을 확인하여, 최적 배지 조성을 확인하고, 배양시간에 따른 균주 증식능 및 효소 활성을 확인하여, 최적 배양 시간을 확인하였으며, 알긴산 농도 및 NaCl 농도에 따른 균주 증식능 및 효소 활성을 확인하여, 최적 알긴산 함량 및 최적 NaCl 함량을 확인하였다. 또한, 반응 온도 및 반응 pH에 따른 효소 활성을 확인하여, 최적 반응 온도 및 반응 pH를 확인하였다. 하기 실험은 모두 각각 3번씩 수행하여, 각 결과의 평균값을 이용하였다.
Specifically, in relation to the culture medium of the strain, first confirming the strain growth capacity and enzyme activity according to the nitrogen source, to determine the optimum medium composition, by confirming the strain growth capacity and enzyme activity according to the culture time, to determine the optimum culture time, By confirming the growth ability and enzyme activity of the strain according to the alginic acid concentration and NaCl concentration, the optimum alginic acid content and the optimum NaCl content was confirmed. In addition, by checking the enzyme activity according to the reaction temperature and the reaction pH, the optimum reaction temperature and reaction pH was confirmed. The following experiments were performed three times each, and the average value of each result was used.
3-1: 3-1: 배양배지의Culture medium 질소원에 따른 According to the nitrogen source 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 의 균주 Strain 증식능Proliferative capacity 및 알긴산 분해능의 확인 And resolution of alginic acid resolution
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v) 및 KCl 0.05%(w/v)의 함량으로 구성된 기본 배지 조성에 NaCl 1.5%(w/v) 및 sodium alginate 1.0%(w/v)과 질소원이 첨가된 배지(pH 7)에 각각 접종하고 배양하였다. 상기 질소원으로 각각 효모 추출물(0.3%(w/v)), 펩톤 (0.5%(w/v)), NH4Cl(0.5%(w/v)), 요소(urea, 0.5%(w/v)) 및 (NH4)2SO4(0.5%(w/v))을 각각의 함량으로 첨가하였다. 상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 2일간 진탕배양하는 방법으로 수행하였다. 상기 배양을 수행한 후, 균주 증식능의 측정은 600 nm에서 O.D.값을 측정하는 방법으로 수행하였고, 알긴산 분해능은 상기 실시예 1의 DNS법으로 각 환원당 생성능을 측정한 후, 최적 조건의 활성을 100%로 하여, 상대 활성(Relative activity(%))으로 나타내었다. 상기 측정결과를 도 3에 나타내었다.HJM27 in the methylobacterium was added to a basic medium composition consisting of 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O and 0.05% (w / v) of KCl. NaCl 1.5% (w / v), sodium alginate 1.0% (w / v) and nitrogen source (pH 7) was inoculated and incubated respectively. Yeast extract (0.3% (w / v)), peptone (0.5% (w / v)), NH 4 Cl (0.5% (w / v)), urea, 0.5% (w / v), respectively. )) And (NH 4 ) 2 SO 4 (0.5% (w / v)) were added in respective amounts. The culture of HJM27 in Methylbacterium was carried out by shaking incubation at 150 rpm and 25 ° C. for 2 days using a thermostat. After the culture was carried out, the strain growth capacity was measured by measuring the OD value at 600 nm, the alginic acid resolution of each reducing sugar production capacity by measuring the DNS method of Example 1, the activity of the
상기 도 3에 나타낸 바와 같이, 균주의 증식능은 효모 추출물이 현저하게 우수하였고, 펩톤의 경우에는 효모 추출물의 약 60% 정도에 해당하는 것으로 확인되었으며, 다른 질소원의 경우에는 균주 증식능이 미비한 것으로 확인되었다. 따라서, 상기 결과로부터 상기 메틸로박테리움 속 HJM27의 배양을 위한 최적 질소원은 효모 추출물인 것으로 확인되었다. 또한, 효소 활성과 관련된 알긴산 분해능의 경우, 펩톤이 가장 우수하였고, 효모 추출물도 펩톤과 유사한 정도의 효소 활성이 확인되었으나, 다른 무기물 질소원들의 경우에는 분해활성이 매우 낮은 것으로 확인되었다. 따라서, 상기 메틸로박테리움 속 HJM27을 이용한 반응액 즉, 생촉매를 제조하는 과정에서, 상기 메틸로박테리움 속 HJM27의 균주 증식을 위해서는 배양배지에 질소원으로 효모 추출물을 첨가하는 것이 바람직하고, 상기 균주 증식 이후에 최종적인 생촉매로 이용될 배양배지에는 질소원으로 펩톤을 첨가하는 것이 바람직한 것으로 평가되었다.
As shown in FIG. 3, the growth ability of the strain was remarkably excellent in the yeast extract, and in the case of peptone, about 60% of the yeast extract was confirmed, and in the case of other nitrogen sources, the strain growth ability was found to be inadequate. . Therefore, it was confirmed from the above results that the optimum nitrogen source for culturing the genus HJM27 in the methylbacterium is a yeast extract. Also, peptone was the best in alginate degradation associated with enzymatic activity, and yeast extract was found to have a similar degree of enzymatic activity as in peptone, but was very low in other mineral nitrogen sources. Therefore, in the process of preparing the reaction solution, that is, the biocatalyst using HJM27 in Methylbacterium, it is preferable to add a yeast extract as a nitrogen source to the culture medium in order to propagate the strain of HMM27 in Methylbacterium. It was evaluated that it is preferable to add peptone as a nitrogen source to the culture medium to be used as the final biocatalyst after strain propagation.
3-2: 배양기간에 따른 3-2: according to the incubation period 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 의 균주 Strain 증식능Proliferative capacity 및 알긴산 분해능의 확인 And resolution of alginic acid resolution
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), NaCl 1.5%(w/v) 및 sodium alginate 1.0%(w/v)의 함량으로 구성된 배지 조성에 질소원으로 펩톤(0.5%(w/v) 및 펩톤(0.5%(w/v))과 효모 추출물(0.3%(w/v))을 각각 첨가한 배지(pH 7)에 접종하여 배양하였다.HJM27 in the methyllobacterium was 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O, 0.05% (w / v) of KCl, 1.5% (w / v) of NaCl. ) And the composition of the content of 1.0% (w / v) sodium alginate as a nitrogen source, peptone (0.5% (w / v) and peptone (0.5% (w / v)) and yeast extract (0.3% (w / v) )) Was inoculated in each of the added medium (pH 7) and cultured.
상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 4일간 진탕배양하는 방법으로 수행하였다. 상기 배양을 수행하면서, 균주 증식능의 측정은 600 nm에서 O.D.값을 측정하는 방법으로 수행하였고, 알긴산 분해능은 상기 실시예 1의 DNS법으로 각 환원당 생성능을 측정한 후, 최적 조건의 활성을 100%로 하여, 상대 활성(Relative activity(%))로 나타내었다. 상기 측정결과를 도 4에 나타내었다.The culture of HJM27 in Methylbacterium was carried out by shaking culture at 150 rpm and 25 ° C. for 4 days using a thermostat. While performing the incubation, strain propagation was measured by measuring the OD value at 600 nm, and alginic acid resolution was measured by the DNS method of Example 1, respectively, and then 100% of the activity under optimum conditions was measured. Relative activity (Relative activity (%)). The measurement results are shown in FIG. 4.
상기 도 4에 나타낸 바와 같이, 균주의 증식능 및 알긴산 분해능과 관련하여, 펩톤과 sodium alginate만을 첨가한 군(PS)에 비하여, 펩톤과 효모 추출물 모두를 첨가한 군(PSY)이 약 200% 이상 우수한 것으로 확인되어, 배지에 질소원으로 펩톤 및 효모 추출물을 함께 첨가하는 것이 바람직한 것으로 평가되었다. 이러한 결과는 미생물의 증식단계에서 효모 추출물이 첨가에 의해 미생물의 증식이 원활하게 이루어지기 때문인 것으로 해석되었다.As shown in FIG. 4, in relation to the growth ability and alginic acid resolution of the strain, the group added with both peptone and yeast extract (PSY) was about 200% or more than the group added with only peptone and sodium alginate (PS). As a result, it was evaluated that the addition of peptone and yeast extract as a nitrogen source to the medium was preferred. These results were interpreted to be due to the smooth growth of the microorganism by the addition of the yeast extract in the growth stage of the microorganism.
또한, 배양기간과 관련하여, 균주의 증식은 접종 후 2일까지는 현저하게 상승하였으나, 3일째에는 다소 감소하는 것으로 확인되어, 최적 배양기간은 2일인 것으로 확인되었다. 또한, 알긴산 분해능과 관련하여, 2일째에 최고의 활성을 나타내었고, 2일이 경과한 시점에서 현저하게 활성이 감소하였다. 또한, 펩톤만을 첨가한 군에서는 배양 1일째에 비하여 배양 2일째 균체수는 감소하였으나, 활성은 현저하게 상승되는 것으로 확인되었다.In addition, in relation to the incubation period, the growth of the strain was significantly increased up to 2 days after inoculation, but decreased slightly on the third day, and the optimal incubation period was confirmed to be 2 days. In addition, with respect to the alginic acid resolution, the highest activity was shown on the second day, and the activity was significantly decreased after two days. In addition, in the group to which only peptone was added, the number of cells was decreased on the second day of culture compared to the first day of culture, but the activity was significantly increased.
상기 결과로부터, 기존 보고된 다른 균주의 경우 알긴산 분해 활성의 최대치가 144시간 배양한 시점이었던 반면에, 상기 메틸로박테리움 속 HJM27는 짧은 시간 배양한 경우에도 균체 증식 및 알긴산 분해능의 향상이 이루어져, 다양한 산업분야에 응용할 수 있을 것으로 예상되었다.From the above results, while the maximum reported alginate degradation activity of the other strains reported previously was 144 hours incubation, the MJ bacterium HJM27 improved cell growth and alginate resolution even when cultured for a short time. It is expected to be applicable to various industries.
또한, 상기 결과로부터 균체 증식율 및 알긴산 분해능의 측면에서 펩톤과 효모 추출물 모두를 첨가한 군(PSY)에서 2일까지 배양하는 것이 가장 바람직할 것으로 예상되었다.
In addition, from the above results, in terms of cell growth rate and alginic acid resolution, it was expected that culturing up to 2 days in the group to which both peptone and yeast extract were added (PSY) was performed.
3-3: 알긴산 함량에 따른 3-3: according to the alginic acid content 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 의 균주 Strain 증식능Proliferative capacity 및 알긴산 분해능의 확인 And resolution of alginic acid resolution
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), NaCl 1.5%(w/v), 펩톤 0.5%(w/v) 및 효모 추출물 0.3%(w/v)의 함량으로 구성된 배지 조성에 sodium alginate의 함량을 조절하여 첨가한 배지(pH 7)에 접종하여 배양하였다.HJM27 in the methyllobacterium was 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O, 0.05% (w / v) of KCl, 1.5% (w / v) of NaCl. ) Was inoculated in a medium (pH 7) added with a controlled content of sodium alginate in a medium composition consisting of 0.5% (w / v) of peptone and 0.3% (w / v) of yeast extract.
상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 2일간 진탕배양하는 방법으로 수행하였다. 상기 배양을 수행한 후, 균주 증식능의 측정은 600 nm에서 O.D.값을 측정하는 방법으로 수행하였고, 알긴산 분해능은 상기 실시예 1의 DNS법으로 각 환원당 생성능을 측정한 후, 최적 조건의 활성을 100%로 하여, 상대 활성(Relative activity(%))로 나타내었다. 상기 측정결과를 도 5에 나타내었다.The culture of HJM27 in Methylbacterium was carried out by shaking incubation at 150 rpm and 25 ° C. for 2 days using a thermostat. After the culture was carried out, the strain growth capacity was measured by measuring the OD value at 600 nm, the alginic acid resolution of each reducing sugar production capacity by measuring the DNS method of Example 1, the activity of the
상기 도 5에 나타낸 바와 같이, 균체의 증식능 및 알긴산 분해능과 관련하여, 알긴산(sodium alginate) 농도가 0.5%(w/v) 이상인 경우에 균체 증식이 원활한 것으로 확인되었다. 또한, 알긴산 분해능과 관련하여, 알긴산 농도가 1.0%(w/v)인 경우에까지 점진적으로 증가하여, 알긴산 농도가 1.0%(w/v)인 것이 최적인 것으로 확인되었고, 알긴산 농도가 1.5%(w/v) 이상인 경우에는 오히려 활성이 감소되는 것으로 확인되었다. 또한, 알긴산이 전혀 첨가되지 않은 경우에도 일정 정도의 활성을 보여, 알긴산이 첨가되지 않은 배지에서 상기 메틸로박테리움 속 HJM27를 배양하는 경우에도 일정 정도의 알긴산 분해효소는 발현되는 것으로 확인되었다. 또한, 효소 활성을 균체성장 정도로 나누어 단위 균체당 효소 활성을 비교한 경우에도 상기 알긴산 농도가 1.0%(w/v)인 경우에 효소 활성이 가장 우수한 것으로 확인되었다.
As shown in FIG. 5, the cell growth was confirmed to be smooth when the concentration of alginic acid (sodium alginate) is 0.5% (w / v) or more in relation to the growth ability and alginic acid resolution of the cells. In addition, with respect to alginic acid resolution, it was gradually increased until the alginic acid concentration was 1.0% (w / v), and it was confirmed that the alginic acid concentration was 1.0% (w / v), and the alginic acid concentration was 1.5% ( In case of w / v) or more, the activity was found to decrease. In addition, even when no alginic acid was added, it showed a certain degree of activity, and it was confirmed that a certain amount of alginic acid degrading enzyme was expressed even when the HJM27 genus Methylbacterium was cultured in a medium without adding alginic acid. In addition, it was confirmed that the enzyme activity was the best when the alginic acid concentration was 1.0% (w / v) even when comparing the enzyme activity per unit cell by dividing the enzyme activity into cell growth.
3-4: 3-4: NaClNaCl 함량에 따른 According to the content 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 의 균주 Strain 증식능Proliferative capacity 및 알긴산 분해능의 확인 And resolution of alginic acid resolution
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), sodium alginate 1.0%(w/v), 펩톤 0.5%(w/v) 및 효모 추출물0.3%(w/v)의 함량으로 구성된 배지 조성에 NaCl의 함량을 0%(w/v)에서 3%(w/v)까지 조절하여 첨가한 배지(pH 7)에 접종하여 배양하였다.HJM27 in the methylobacterium was 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O, 0.05% (w / v) of KCl, 1.0% (w / v) of sodium alginate. v), NaCl content was adjusted from 0% (w / v) to 3% (w / v) in a medium composition consisting of 0.5% (w / v) peptone and 0.3% (w / v) yeast extract. The culture was inoculated with the added medium (pH 7).
상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 2일간 진탕배양하는 방법으로 수행하였다. 상기 배양 후, 균주 증식능의 측정은 600 nm에서 O.D.값을 측정하는 방법으로 수행하였고, 알긴산 분해능은 상기 실시예 1의 DNS법으로 각 환원당 생성능(g/L)을 측정하였다. 또한, 균체당 알긴산 분해능을 확인하기 위하여, 상기 측정된 환원당 생성량을 OD600값으로 나누었다. 상기 측정결과 및 계산결과를 하기 표 1에 나타내었다.The culture of HJM27 in Methylbacterium was carried out by shaking incubation at 150 rpm and 25 ° C. for 2 days using a thermostat. After the culture, strain propagation capacity was measured by measuring the OD value at 600 nm, and alginic acid resolution was measured by reducing sugar production ability (g / L) by the DNS method of Example 1. In addition, in order to confirm the alginate resolution per cell, the measured amount of reducing sugar produced was divided by the OD 600 value. The measurement results and calculation results are shown in Table 1 below.
상기 표 1에 나타낸 바와 같이, 균체의 증식능과 관련하여, NaCl 함량이 2.5%(w/v)일 때 최적인 것으로 확인되었고, 1.0(w/v)일 때도 우수한 것으로 확인되었다. 이와 같이 성장의 쌍고점을 나타내는 것은 균주가 성장하면서 floc을 형성하기 때문인 것으로 예상되었다. 한편, 상기 NaCl 함량이 3.0%(w/v)일 때 성장이 급격히 저하되었으므로, 이로부터 상기 메틸로박테리움 속 HJM27은 호염성이 아닌 내염성(halotolerant) 균주인 것으로 판단되었다.As shown in Table 1 above, the NaCl content was found to be optimal when the NaCl content was 2.5% (w / v) with respect to the proliferation ability of the cells, and was also excellent when the 1.0 (w / v). The high peak of growth was expected to be due to the formation of floc as the strain grows. On the other hand, the growth was sharply reduced when the NaCl content is 3.0% (w / v), from which it was determined that the genus HJM27 is a halolerant strain rather than basophils.
또한, 알긴산 분해능과 관련하여, NaCl 함량이 1.5%(w/v)인 경우에 생성된 환원당 량 및 단위 균체당 효소 활성(Reduced sugar per Biomass)이 가장 우수한 것으로 확인되었다.In addition, with respect to the alginic acid resolution, it was confirmed that the reduced sugar equivalent and the enzyme activity per unit cell produced (Reduced sugar per Biomass) was the best when the NaCl content is 1.5% (w / v).
따라서, 상기 메틸로박테리움 속 HJM27의 배양을 통한 생촉매의 제조를 위한 최적 NaCl함량은 1.5%(w/v)인 것으로 확인되었다.
Therefore, it was confirmed that the optimal NaCl content for the preparation of the biocatalyst through the culturing of HJM27 in Methylbacterium was 1.5% (w / v).
3-5: 3-5: 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 이 생산하는 알긴산 분해효소의 온도에 따른 알긴산 분해능 측정Degradation of Alginate with Temperature of Alginate Degrading Enzymes
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), sodium alginate 1.0%(w/v), NaCl 0.5%(w/v), 펩톤 0.5%(w/v) 및 효모 추출물 0.3%(w/v)의 함량으로 구성된 배지(pH 7)에 접종하여 배양하였다. 상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 2일간 진탕배양하는 방법으로 수행하였다. 상기 배양 후, 상기 반응온도를 20℃ 내지 40℃로 조절하면서 상기 실시예 1의 DNS법으로 각 환원당 생성능(g/L)을 측정하였다. 상기 측정결과는 도 6에 나타내었다.HJM27 in the methylobacterium was 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O, 0.05% (w / v) of KCl, 1.0% (w / v) of sodium alginate. v), incubated in a medium (pH 7) consisting of NaCl 0.5% (w / v), peptone 0.5% (w / v) and yeast extract 0.3% (w / v). The culture of HJM27 in Methylbacterium was carried out by shaking incubation at 150 rpm and 25 ° C. for 2 days using a thermostat. After the incubation, the reducing sugar production ability (g / L) was measured by the DNS method of Example 1 while adjusting the reaction temperature to 20 ℃ to 40 ℃. The measurement results are shown in FIG. 6.
상기 도 6에 나타낸 바와 같이, 상기 생촉매액의 알긴산 분해능은 25℃에서 최고치를 나타냈으며, 20℃에서 최고치의 상대치로 나타낸 알긴산 분해능 즉, 상대활성이 약 25%이고, 30℃ 이상에서 거의 활성이 나타나지 않는 것으로 확인되었다. 따라서, 상기 메틸로박테리움 속 HJM27을 이용하여 제조한 생촉매의 최적 반응온도는 25℃인 것으로 확인되었다.
As shown in FIG. 6, the alginic acid resolution of the biocatalyst solution showed the highest value at 25 ° C., and the alginic acid resolution represented by the relative value of the highest value at 20 ° C., that is, the relative activity was about 25%, was nearly active at 30 ° C. or higher. It was confirmed that this did not appear. Therefore, it was confirmed that the optimum reaction temperature of the biocatalyst prepared using the MJ bacterium HJM27 was 25 ° C.
3-6: 3-6: 메틸로박테리움Methyl Bacterium 속 genus HJM27HJM27 이 생산하는 알긴산 분해효소의 Of alginate to produce pHpH 에 따른 알긴산 분해능 측정Resolution of alginic acid according to
상기 메틸로박테리움 속 HJM27를 KH2PO4 0.1%(w/v), FeSO4·7H2O 0.05%(w/v), KCl 0.05%(w/v), sodium alginate 1.0%(w/v), NaCl 0.5%(w/v), 펩톤 0.5%(w/v) 및 효모 추출물 0.3%(w/v)의 함량으로 구성된 배지(pH 7)에 접종하여 배양하였다. 상기 메틸로박테리움 속 HJM27의 배양은 항온조를 이용하여 150 rpm 및 25℃의 조건에서 2일간 진탕배양하는 방법으로 수행하였다. 상기 배양 후, 상기 반응pH를 pH 3 내지 pH 11로 조절하면서 상기 실시예 1의 DNS법으로 각 환원당 생성능(g/L)을 측정하였다. 상기 측정결과는 도 7에 나타내었다.HJM27 in the methylobacterium was 0.1% (w / v) of KH 2 PO 4, 0.05% (w / v) of FeSO 4 .7H 2 O, 0.05% (w / v) of KCl, 1.0% (w / v) of sodium alginate. v), incubated in a medium (pH 7) consisting of NaCl 0.5% (w / v), peptone 0.5% (w / v) and yeast extract 0.3% (w / v). The culture of HJM27 in Methylbacterium was carried out by shaking incubation at 150 rpm and 25 ° C. for 2 days using a thermostat. After the incubation, each reducing sugar generation capacity (g / L) was measured by the DNS method of Example 1 while adjusting the reaction pH to
구체적으로, 상기 pH의 조절은 상기 반응액에 200 mM 아세트산 나트륨(sodium acetate) 완충용액(pH 3 내지 pH 6), 40 mM 인산 나트륨(sodium phosphate) 완충용액(pH 6 내지 pH 8) 및 100 mM glycine-NaOH 완충용액(pH 8 내지 pH 11)을 이용하였다.Specifically, the pH is adjusted to 200 mM sodium acetate buffer (
상기 도 7에 나타낸 바와 같이, 상기 pH에 따른 알긴산 분해능은 알카리성 영역인 pH 9.0에서 최고치를 나타내어 상기 메틸로박테리움 속 HJM27이 생산하는 알긴산 분해효소의 최적 pH는 9.0인 것으로 확인되었다. 완충용액 종류에 따른 오차를 확인하기 위해, 재차 300 mM GTA 완충용액(3,3-dimehtylglutarid acid, Tris(hydrosymethyl) aminomethane, 2-amino-2-methyl-1,3-propanediol, pH 3 내지 pH 10)을 이용하여 측정한 결과에서도 동일한 결과가 확인되었다. 최적 pH인 pH 9를 기준으로 이보다 산성 또는 알카리성인 조건에서는 산성 또는 알카리성이 강해질수록 알긴산 분해능이 저하되는 것으로 확인되었다.As shown in FIG. 7, the alginic acid degradability according to the pH showed the highest value in the alkaline region pH 9.0, and it was confirmed that the optimal pH of the alginic acid degrading enzyme produced by the HJM27 in the methyllobacterium was 9.0. In order to check the error according to the type of buffer solution, again, 300 mM GTA buffer solution (3,3-dimehtylglutarid acid, Tris (hydrosymethyl) aminomethane, 2-amino-2-methyl-1,3-propanediol,
따라서, 상기 메틸로박테리움 속 HJM27을 이용하여 제조한 생촉매의 최적 반응pH는 pH 9인 것으로 확인되었다. 추가적으로, 상기 메틸로박테리움 속 HJM27의 배양액으로부터 제조된 생촉매액(배양액에서 균체를 제거한 상징액)을 이용하여, 전분, 카라기난, 펙틴 및 한천 등의 다당류에 대한 분해활성을 측정한 결과, 다른 다당류에 대해서는 분해활성이 나타나지 않고, 알긴산에 대해서만 분해활성이 나타나, 상기 메틸로박테리움 속 HJM27가 생산하는 효소는 알긴산 분해효소인 것이 확인되었다.
Therefore, the optimum reaction pH of the biocatalyst prepared using the MJ bacterium HJM27 was found to be pH 9. In addition, by using the biocatalyst solution prepared from the culture medium of HJM27 in Methylbacterium (a supernatant removed from the culture medium), the degradation activity of polysaccharides such as starch, carrageenan, pectin, and agar was measured. It was confirmed that degrading activity was not observed with respect to alginic acid, and that the enzyme produced by HJM27 in the methyllobacterium was alginic acid degrading enzyme.
상기와 같은 결과에 의할 때, 본 발명인 메틸로박테리움 속 HJM27은 알긴산을 분해하여 알긴산올로고머를 생산할 수 있는 알긴산 분해효소를 제조할 수 있으며, 상기 메틸로박테리움 속 HJM27로부터 알긴산 분해효소를 생산하는 최적 조건 및 상기 알긴산 분해효소의 반응 최적 조건이 확인되었으므로, 상기 메틸로박테리움 속 HJM27은 의약품 및 기능성 식품과 관련된 산업 및 바이오에너지 관련 산업을 포함한 다양한 산업분야에 응용될 수 있을 것으로 기대된다.
Based on the above results, the present invention can be prepared alginate degrading enzyme that can produce alginate oligomer by decomposing the alginic acid HJM27 in the present invention, the alginate degrading enzyme from the HJM27 of the methyllobacterium genus Since the optimum conditions for producing and optimum reaction conditions of the alginic acid degrading enzyme have been confirmed, the HJM27 in the methyllobacterium is expected to be applied to various industrial fields including industries related to pharmaceuticals and functional foods and bioenergy related industries. do.
Claims (4)
를 포함하는 제2항의 생촉매 제조방법.Comprising: a yeast extract (Yeast Extract) and peptone (Peptone) is included, the I NaCl content of the medium 1.5% (w / v) of tumefaciens sp from the culture medium as methyl (Methylobacterium sp, KCTC 11680BP.) Inoculation; And culturing the strain inoculated in the culture medium for 45 hours to 51 hours.
Biocatalyst production method of claim 2 comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100053583A KR101229055B1 (en) | 2010-06-07 | 2010-06-07 | Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100053583A KR101229055B1 (en) | 2010-06-07 | 2010-06-07 | Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110133917A KR20110133917A (en) | 2011-12-14 |
KR101229055B1 true KR101229055B1 (en) | 2013-02-04 |
Family
ID=45501403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100053583A Active KR101229055B1 (en) | 2010-06-07 | 2010-06-07 | Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101229055B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020013801A (en) * | 2000-08-12 | 2002-02-21 | 이길환 | Manufacturing method of activated carbon and regenerating method of spent activated carbon using microwave |
KR20170035004A (en) | 2015-09-22 | 2017-03-30 | 신라대학교 산학협력단 | A method of preparing alginate-oligomer and composition for treating or preventing obesity containing the same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201322777D0 (en) | 2013-12-20 | 2014-02-05 | Algipharma As | Use of alginate oligomers as blood anticoagulants |
KR102399220B1 (en) * | 2020-10-20 | 2022-05-19 | 주경준 | Manufacturing method of composition for scalp protection and hair growth acceleration |
-
2010
- 2010-06-07 KR KR1020100053583A patent/KR101229055B1/en active Active
Non-Patent Citations (2)
Title |
---|
PARK, H.H., Distribution of Alginate Degrading Bacteria in Korean Pickled Hairtail Guts, 2010 한국생물공학회 춘계학술발표대회 및 국제심포지움 초록. (2010.04.15-16.) * |
PARK, H.H., Distribution of Alginate Degrading Bacteria in Korean Pickled Hairtail Guts, 2010 한국생물공학회 춘계학술발표대회 및 국제심포지움 초록. (2010.04.15-16.)* |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020013801A (en) * | 2000-08-12 | 2002-02-21 | 이길환 | Manufacturing method of activated carbon and regenerating method of spent activated carbon using microwave |
KR20170035004A (en) | 2015-09-22 | 2017-03-30 | 신라대학교 산학협력단 | A method of preparing alginate-oligomer and composition for treating or preventing obesity containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20110133917A (en) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Inoue et al. | Characterization of an alginate lyase, FlAlyA, from Flavobacterium sp. strain UMI-01 and its expression in Escherichia coli | |
Fu et al. | An acidic, thermostable exochitinase with β-N-acetylglucosaminidase activity from Paenibacillus barengoltzii converting chitin to N-acetyl glucosamine | |
CN102517235B (en) | Bacillus subtilis | |
KR101207584B1 (en) | Strain of sanguibacter keddieii having an alginate-decomposition activity and method of producing alginate-oligomer using the same | |
Sitanggang et al. | Aspects of glucosamine production using microorganisms | |
KR101239757B1 (en) | Novel paenibacillus lautus gd-a2 producing breaking down alginate lyase, biocatalyst for alginic acid and method for manufacturing alginic acid oligosaccaride by using the same | |
CN105018544B (en) | With the carrageenan oligosaccharide and its preparation method and application for promoting sea cucumber growth and degeneration-resistant effect | |
Ding et al. | A Chitosanase mutant from Streptomyces sp. N174 prefers to produce functional chitopentasaccharide | |
Dutta et al. | L-asparaginase and L-glutaminase from Aspergillus fumigatus WL002: Production and some physicochemical properties | |
Shahbaz et al. | Cloning, isolation, and characterization of novel chitinase-producing bacterial strain UM01 (Myxococcus fulvus) | |
Sinha et al. | Microbial degradation of chitin waste for production of chitosanase and food related bioactive compounds | |
KR101229055B1 (en) | Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same | |
Zilda et al. | A novel Bacillus sp. isolated from rotten seaweed: Identification and characterization alginate lyase its produced | |
Waghmare et al. | Chitobiose production by using a novel thermostable chitinase from Bacillus licheniformis strain JS isolated from a mushroom bed | |
Xu et al. | Purification and characterization of cold-adapted and salt-tolerant dextranase from Cellulosimicrobium sp. THN1 and its potential application for treatment of dental plaque | |
Ning et al. | Alkalic dextranase produced by marine bacterium Cellulosimicrobium sp. PX02 and its application | |
KR100876662B1 (en) | Streptomyces spp. And alginate degrading enzymes having alginate hydrolytic activity | |
Lavin et al. | Isolation and characterization of an Antarctic Flavobacterium strain with agarase and alginate lyase activities | |
Tamilmani et al. | Production of an extra cellular feather degrading enzyme by Bacillus licheniformis isolated from poultry farm soil in Namakkal district (Tamilnadu) | |
Wei et al. | The potential of degrading natural chitinous wastes to oligosaccharides by chitinolytic enzymes from two Talaromyces sp. isolated from rotten insects (Hermetia illucens) under solid state fermentation | |
US7150985B2 (en) | Bacteriolytic complex, method for producing said complex and strain for carrying out said method | |
KR20110115905A (en) | Novel Beta-Agarases and Their Uses | |
Singh et al. | L-asparaginase production by a new isolate Bacillus aryabhattai strain ITBHU02 in solid state culture | |
Ziayoddin et al. | Isolation of agar degrading bacterium Pseudomonas aeruginosa ZSL-2 from a marine sample | |
Sharma et al. | Improvement in inulinase production by simultaneous action of physical and chemical mutagenesis in Penicillium purpurogenum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20100607 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111116 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20121029 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130128 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130129 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20151207 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20151207 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20161208 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20161208 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180116 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20180116 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190520 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20190520 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20200227 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200227 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20201030 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20211022 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20231129 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20241023 Start annual number: 13 End annual number: 13 |